Neil Josephson insider trades

Open-market stock purchases and sales by Neil Josephson, Chief Medical Officer at Iambic Therapeutics, Inc, from SEC Form 4 filings since Jul 6, 2021.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +97%.

Recent trades

DateStockTradeValue
Oct 14, 2026IAM Iambic Therapeutics, IncBought (not open market)—
Oct 14, 2026IAM Iambic Therapeutics, IncBought (not open market)—

Companies traded

  • IAM Iambic Therapeutics, Inc: other filings, last Oct 14, 2026
  • ZYME Zymeworks BC Inc: 2 buys, 3 sales, last Nov 10, 2022

Get free alerts when Neil Josephson files a new trade →